Trinity Biotech plc (TRIB)

Trinity Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5.17	3.69	6.58	25.91	27.33
Cash & Short-Term Investments	5.17	3.69	6.58	25.91	27.33
Cash Growth	39.99%	-43.89%	-74.61%	-5.18%	66.63%
Accounts Receivable	13.88	11.34	13.45	14.17	21.42
Other Receivables	0.73	1.67	2.21	1.54	3.18
Receivables	14.6	13.01	15.66	15.71	24.6
Inventory	19.37	19.93	22.5	29.12	30.22
Prepaid Expenses	1.98	2.04	1.93	1.95	1.16
Other Current Assets	-	0.37	-	-	-
Total Current Assets	41.12	39.04	46.67	72.69	83.3
Property, Plant & Equipment	4.62	1.89	5.68	5.92	8.55
Long-Term Investments	2.46	-	-	-	-
Goodwill	13.84	-	12.54	12.54	12.59
Other Intangible Assets	16.55	1.17	5.72	5.77	7.83
Long-Term Accounts Receivable	-	0.04	0.08	0.15	0.29
Long-Term Deferred Tax Assets	3.55	1.98	4.22	4.1	4.18
Long-Term Deferred Charges	20.95	15.1	17.01	17.68	13.44
Other Long-Term Assets	0.19	0.22	0.18	0.06	0.21
Total Assets	103.29	59.44	92.1	118.9	130.4
Accounts Payable	6.83	3.89	6.21	6.76	7.1
Accrued Expenses	14.37	8.07	9.06	8.12	9.69
Short-Term Debt	-	-	-	0.03	2.91
Current Portion of Long-Term Debt	0.21	0.21	0.21	83.31	-
Current Portion of Leases	2.29	1.69	1.68	1.98	2.15
Current Income Taxes Payable	0.36	0.28	0.03	0.02	0.15
Current Unearned Revenue	0.2	0.05	0.11	0.21	4.45
Other Current Liabilities	7.84	0.85	0.05	0.05	0.61
Total Current Liabilities	32.1	15.04	17.34	100.49	27.06
Long-Term Debt	87.79	54.65	58.05	-	82.7
Long-Term Leases	10.48	10.87	12.27	13.87	16.59
Long-Term Deferred Tax Liabilities	4.56	2.3	5.06	4.86	4.91
Other Long-Term Liabilities	3.55	0.53	1.57	-	1.37
Total Liabilities	138.47	83.38	94.28	119.21	132.62
Common Stock	4.19	1.97	1.96	1.21	1.21
Additional Paid-In Capital	63.4	46.62	46.46	16.19	16.19
Retained Earnings	-79.12	-48.64	-26.7	12.56	10.57
Treasury Stock	-24.92	-24.92	-24.92	-24.92	-24.92
Comprehensive Income & Other	1.27	1.03	1.02	-5.36	-5.27
Shareholders' Equity	-35.18	-23.95	-2.18	-0.32	-2.22
Total Liabilities & Equity	103.29	59.44	92.1	118.9	130.4
Total Debt	100.76	67.43	72.2	99.19	104.34
Net Cash (Debt)	-95.6	-63.74	-65.62	-73.28	-77.01
Net Cash Per Share	-5.32	-8.33	-9.73	-17.53	-18.42
Filing Date Shares Outstanding	18.63	9.47	7.64	5.38	4.18
Total Common Shares Outstanding	17.96	7.67	7.62	4.18	4.18
Working Capital	9.03	24.01	29.33	-27.8	56.24
Book Value Per Share	-1.96	-3.12	-0.29	-0.08	-0.53
Tangible Book Value	-65.57	-25.12	-20.44	-18.62	-22.64
Tangible Book Value Per Share	-3.65	-3.28	-2.68	-4.45	-5.41
Land	26.78	24.27	24.68	24.33	24.29
Machinery	41.03	39.04	38.22	36.54	38.15
Leasehold Improvements	2.81	2.76	2.7	2.59	2.67

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q